Formononetin Exerts Neuroprotection in Parkinson’s Disease via the Activation of the Nrf2 Signaling Pathway
Parkinson’s disease (PD) is a prevalent neurodegenerative disease for which no effective treatment currently exists. In this study, we identified formononetin (FMN), a neuroprotective component found in herbal medicines such as <i>Astragalus membranaceus</i> and <i>Glycyrrhiza ural...
Saved in:
| Main Authors: | Xiaotong Wang, Nianxin Kang, Ying Liu, Guojie Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/29/22/5364 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Formononetin promotes porcine oocytes maturation and improves embryonic development by reducing oxidative stress
by: Na Wang, et al.
Published: (2025-01-01) -
Repurposing of epalrestat for neuroprotection in parkinson’s disease via activation of the KEAP1/Nrf2 pathway
by: Huafang Jia, et al.
Published: (2025-04-01) -
The Role of Formononetin in Cerebral Ischemia-Reperfusion Injury: A New Mediator of c-Fos/IL-10/STAT3 Signaling Pathway
by: Ming Yan, et al.
Published: (2025-05-01) -
Therapeutic potential of formononetin in cirrhotic portal hypertension: modulating hepatic fibrosis, macrophage polarization, and lymphangiogenesis
by: Zhenghao Wu, et al.
Published: (2025-08-01) -
Formononetin: a review of its source, pharmacology, drug combination, toxicity, derivatives, and drug delivery systems
by: Min Jin, et al.
Published: (2025-03-01)